Cheat sheet

IC&RC AADC Cheat Sheet

Quick Facts

Exam
IC&RC AADC
Credential
Advanced Addiction Counselor
Questions
150 (125 scored)
Time
3 hours
Pass
Scaled 500/800
Level
Master's required
Blueprint
Mar 16 2026
Retake
90-day minimum wait

ASAM Six Dimensions

Dims 1-5 place; Dimension 6 decides with client.

1: Intox/withdrawal2: Biomedical3: Psychiatric/cognitive4: Use-related risk5: Recovery environment6: Person-centered

Screening vs Assessment

Screening

  • Brief flag
  • Decides next step
  • Not a diagnosis

Assessment

  • Deep biopsychosocial process
  • Supports the diagnosis
  • Ongoing, not one-time

Flag vs formulate

Level-of-Care Picker

  1. High Dimension 1 risk→Manage intox/withdrawal(Medical support)
  2. High Dimension 2 risk→Address biomedical needs(Coordinate medical care)
  3. High Dimension 3 risk→Treat psychiatric symptoms(Integrated care needed)
  4. High Dimension 4 risk→Raise level of care(Relapse risk driver)
  5. Unsafe Dimension 5→More structured setting(Environment risk driver)
  6. Dimension 6 barriers→Shared decision-making(Not the placement calc)
  7. Any dimension high→Consider higher level(One dimension can drive)
  8. All dimensions stable→Step down level(Documented milestones needed)

DSM-5-TR Severity

11 criteria
Total DSM-5-TR SUD criteria
Mild SUD
2-3 criteria met
Moderate SUD
4-5 criteria met
Severe SUD
6 or more criteria
12-month window
Criteria counting timeframe
Substance-induced
Clears as substance clears
Independent disorder
Predates use, persists ~1 month

DSM-5-TR Severity

2-3 mild, 4-5 moderate, 6-plus severe.

11 criteria total12-month windowMild: 2-3Moderate: 4-5Severe: 6-plus

Substance-Induced vs Independent

Substance-induced

  • Starts with use
  • Clears with time
  • Expected to resolve

Independent

  • Predates the use
  • Persists about a month
  • Needs its own treatment

Clears vs persists

ASAM 4th Ed Dimensions

Dimension 1
Intox/withdrawal, addiction meds
Dimension 2
Biomedical conditions
Dimension 3
Psychiatric, cognitive conditions
Dimension 4
Substance use-related risks
Dimension 5
Recovery environment interactions
Dimension 6
Person-centered considerations
Dims 1-5
Set level-of-care recommendation

Stages Of Change

Precontemplation to maintenance, five stages total.

Precontemplation: not yetContemplation: weighing itPreparation: planning itAction: doing itMaintenance: sustaining it

Assessment Practice

Bio/psycho/social/spiritual
Four-domain clinical interview
Cultural fit
Match tool to population
Qualified interpreter
Not a family member
MAT screening
Substance, stability, prior response
Danger screening
Ideation, plan, means, intent
Co-occurring dx
Formulate both diagnoses together
Results discussion
Collaborative, not one-way

Stages Of Change

Precontemplation
Not yet considering change
Contemplation
Weighing pros and cons
Preparation
Planning the change step
Action
Actively changing behavior
Maintenance
Sustaining the change
Style match
Fit approach to stage

Integrated vs Sequential Treatment

Integrated

  • One coordinated plan
  • TIP 42 preferred model
  • Avoids conflicting guidance

Sequential

  • Treats one disorder first
  • Then treats the other
  • Can delay second disorder

Together vs one-at-a-time

SMART Treatment Plans

Specific
Clear target behavior
Measurable
Verifiable in session
Achievable
Realistic for this client
Relevant
Tied to client's goals
Time-bound
Has a target date
Collaborative
Client co-authors the goal

Warm Handoff vs Passive Referral

Warm handoff

  • Active, scheduled connection
  • Happens before care ends
  • Lower drop-off rate

Passive referral

  • Just a name or number
  • Client follows up alone
  • Higher drop-off rate

Connects vs hands off

Recovery Pathways + Supports

12-step
Mutual-help recovery pathway
MAT pathway
Medication-supported recovery
Harm reduction
Reduces risk, not abstinence-only
Faith-based
Values-driven recovery pathway
Secular pathway
Non-spiritual recovery option
Formal resource
Licensed, structured service
Informal support
Peer, faith, mutual-help

Referral + Care Coordination

Warm handoff
Active connection before discharge
Passive referral
Name only, high drop-off
Referral note
Contact, consent, outcome, follow-up
Scope boundary
No meds, no override
Step-down
Driven by documented milestones
Step-up
Driven by new risk

Co-Occurring Treatment Models

Sequential
One disorder, then other
Parallel
Both treated, separate providers
Integrated
Both, one coordinated plan
TIP 42
SAMHSA co-occurring guide
Preferred model
Integrated treatment, per TIP 42

MI Four Processes

Engage, focus, evoke, plan in order.

Engage: build relationshipFocus: pick directionEvoke: draw out talkPlan: commit to steps

Transference vs Countertransference

Transference

  • Client's redirected feelings
  • About the client's past
  • Client's reaction to counselor

Countertransference

  • Counselor's own reaction
  • From counselor's own history
  • Counselor manages it, not client

Client vs counselor origin

Intervention Picker

  1. Low motivation to change→MI(Resolves ambivalence)
  2. Need a quick boost→MET(Brief feedback session)
  3. Distorted relapse-risk thoughts→CBT(Restructure the thought)
  4. Need verified abstinence→Contingency management(Reinforce the behavior)
  5. Ambivalent about meetings→12-Step Facilitation(Engage mutual-help group)
  6. Craving in the moment→MBRP(Urge surfing skill)
  7. Trauma, not ready to process→Seeking Safety(Present-focused, skills-based)
  8. Adolescent client's substance use→MDFT, BSFT, or FFT(Family-based model)

Evidence-Based Interventions

CBT
Restructures relapse-risk thoughts
MI
Resolves ambivalence about change
MET
Brief, feedback-driven intervention
Contingency mgmt
Reinforces verified target behavior
12-Step Facilitation
Actively engages mutual-help groups
MBRP
Urge-surfing core skill
Seeking Safety
Present-focused trauma model

MAT Mechanisms

Agonist, partial agonist, antagonist: three drug classes.

Methadone: full agonistBuprenorphine: partial, ceiling effectNaltrexone: antagonist, blocks receptor

Pharmacotherapy Picker

  1. Opioid use, in withdrawal→Methadone or buprenorphine(OTP or office-based Rx)
  2. Opioid use, needs antagonist→XR-naltrexone(Needs 7-10 opioid-free days)
  3. Alcohol use, liver concern→Acamprosate(Renally cleared option)
  4. Alcohol use, needs deterrent→Disulfiram(Requires full abstinence)
  5. Tobacco use disorder→Varenicline, bupropion, or NRT(Prescriber-guided combination possible)
  6. Too soon after agonist→Avoid early buprenorphine(Risk of precipitated withdrawal)

MI Four Processes

Engaging
Build the working relationship
Focusing
Agree on a direction
Evoking
Draw out change talk
Planning
Commit to specific steps
Sequence matters
Each step builds prior

Family + Trauma Models

MDFT
Multidimensional family therapy
BSFT
Brief strategic family therapy
FFT
Functional family therapy
Family embedding
Use disorder as family pattern
Adolescent focus
Treat family, not solo client

Pharmacotherapy

Methadone
Full agonist, OTP-only
Buprenorphine
Partial agonist, ceiling effect
XR-naltrexone
Antagonist, needs opioid-free days
7-10 days
Opioid-free before XR-naltrexone
Naltrexone (alcohol)
Reduces alcohol cravings
Acamprosate
Preferred with liver concerns
Disulfiram
Deterrent, needs full abstinence
Varenicline
Tobacco cessation medication
NRT
Patch, gum, lozenge, spray

Withdrawal + Safety

Alcohol withdrawal
Seizure and delirium risk
Sedative withdrawal
Can be fatal too
Opioid withdrawal
Rarely life-threatening alone
Post-tolerance risk
Overdose danger after abstinence
Medically managed
Needed for alcohol, sedatives

Supervision vs Consultation

Supervision

  • Ongoing and evaluative
  • Shared clinical responsibility
  • Assesses supervisee competence

Consultation

  • Voluntary, as needed
  • Non-evaluative input only
  • Counselor keeps responsibility

Oversight vs advice

Confidentiality Picker

  1. Outside vendor needs data→QSOA(Binds vendor to Part 2)
  2. Subpoena alone arrives→Do not release(Court order still required)
  3. Court order is sought→Notify client and holder(Both get a chance)
  4. Unsure of own judgment→Consultation(Voluntary, non-evaluative input)
  5. Formal competence review needed→Supervision(Shared clinical responsibility)
  6. Colleague acts unethically→Report to the board(If informal fix fails)

42 CFR Part 2 Basics

Part 2 program
Federally assisted SUD provider
Stricter than HIPAA
SUD-specific extra protections
Acknowledgment ban
No confirming SUD-only facility
Subpoena alone
Not enough to disclose
Court order
Required, with notice first
2024 Final Rule
Compliance date Feb 16 2026
QSOA
Binds vendor to Part 2
Single consent
Covers TPO disclosures now
Still protected
No use against patient

Boundary Crossing vs Violation

Crossing

  • Stays in client's interest
  • Gets reflected on after
  • Not exploitive

Violation

  • Exploits counselor's power
  • Harms the client
  • Personal benefit sought

Benign vs harmful

Duty + Telehealth

Duty to warn
Set by state, not IC&RC
Telehealth consent
Covers connection failure, ID
EHR + tech
Recognize service-delivery advances
Jurisdiction rules
Confidentiality exceptions vary by state

Court Order vs Subpoena

Court order

  • Authorizes SUD disclosure
  • Requires notice first
  • Gives chance to respond

Subpoena alone

  • Not enough by itself
  • Common compliance error
  • No SUD release yet

Authorizes vs insufficient

Supervision + Practice

Supervision
Ongoing, evaluative, shared responsibility
Consultation
Voluntary, non-evaluative input
EBP
Research plus expertise plus values
Implicit bias
Automatic, affects clinical decisions
Explicit bias
Consciously held attitude
Unethical colleague
Report to board or supervisor

Boundaries + Bias

Boundary crossing
Client's interest, reflected on
Boundary violation
Exploits power, harms client
Cultural responsiveness
Adapt, don't assume, ongoing
DEIB
Diversity, equity, inclusion, belonging
Implicit in decisions
Shows up in referral patterns

Common Traps

Screening confused with assessment

Screening only flags risk ≠ Assessment supports the diagnosis

Readiness dimension assumed missing

3rd edition had Dimension 4 ≠ 4th edition folds into Dimension 6

Subpoena treated as sufficient

Subpoena alone is not enough ≠ Court order is required

Consultation treated as supervision

Consultation stays voluntary, non-evaluative ≠ Supervision shares clinical responsibility

Buprenorphine started too early

Too soon after full agonist ≠ Can precipitate acute withdrawal

Opioid withdrawal assumed lethal

Rarely life-threatening by itself ≠ Main danger is later overdose

Every crossing called a violation

Crossing still serves the client ≠ Violation exploits counselor power

Last Minute

  1. 1.Counseling and Education 30%, largest
  2. 2.150 items: 125 scored + 25 pretest
  3. 3.3-hour time limit
  4. 4.Pass = scaled 500 of 800
  5. 5.Blueprint effective March 16 2026
  6. 6.Retake wait = 90 days min
  7. 7.ASAM 4th edition = 6 dimensions
  8. 8.Dim 6 = person-centered, not placement
  9. 9.Part 2 disclosure needs court order
  10. 10.2024 Rule compliance = Feb 2026
  11. 11.Supervision shares responsibility; consult does not
  12. 12.Integrated care preferred for co-occurring
Same family resources

Explore More IC&RC Addiction Professional Exams

Continue into nearby exams from the same family. Each card keeps practice questions, study guides, flashcards, videos, and articles in one place.